GH1 and hereditary endocrine growth disease: From a practical perspective, this combined set of findings suggests that allowing flexibility in the timing of GH injections is a viable approach to GH therapy that prioritizes patient-centered care, potentially improving treatment adherence and outcomes without compromising sleep health or growth metrics in children with growth disorders.